Two South Korean Pharma Companies Set Up R&D Centers

---

Researched by Industrial Info Resources (Sugar Land, Texas)--Pharmaceutical and chemical company Yuhan Corporation (Seoul, South Korea) recently reached an agreement with Gunpo City, in South Korea's Gyeonggi Province, to invest 80 billion won (US$59.2 million) in its proposed Bio Research Center and Affiliated CMC (Medicine Quality Management) Center.

The facility will be located in the industrial area of Gunpo's Dangjeong-dong district. Yuhan and Gunpo City believe the project will bolster the local community, while strengthening Yuhan's research and development (R&D) of new drugs for the global market. Subscribers to Industrial Info's Global Market Intelligence (GMI) Pharmaceutical & Biotech Project and Plant databases can learn more from a detailed project report and plant profile.

Another Korean pharmaceutical company, Yuyu Healthcare (Seoul), is heading to Gangwon-do, in the Gangwon province, to develop functional food materials and products to prevent hair loss and promote hair growth. The project will be supported by Gangwon, which will help the company acquire raw materials and equipment. Subscribers can learn more from a detailed project report and plant profile.

Industrial Info Resources (IIR) is the leading provider of industrial market intelligence. Since 1983, IIR has provided comprehensive research, news and analysis on the industrial process, manufacturing and energy related industries. IIR's Global Market Intelligence (GMI) platform helps companies identify and pursue trends across multiple markets with access to real, qualified and validated plant and project opportunities. Across the world, IIR is tracking more than 200,000 current and future projects worth $17.8 trillion (USD).